Lisa F. Falcon, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 312 Walter E Foran Blvd, Flemington, NJ 08822 Phone: 908-782-4700 Fax: 908-782-3785 |
Dr. Sophia Yeh, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 27 Bluebird Ct, Flemington, NJ 08822 Phone: 908-782-4228 Fax: 908-782-9798 |
Andrew S Greenberg, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-495-6325 Fax: 908-788-6106 |
Andrew Cortes, M.D. Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 2100 Westcott Drive, Flemington, NJ 08822 Phone: 631-902-9033 |
Dr. Robert Stanley Boggiano, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 33 Deerpath Rd, Flemington, NJ 08822 Phone: 908-782-4256 |
Dr. Ruth S Feldman, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 121 State Route 31, Flemington, NJ 08822 Phone: 908-782-4700 |
Payal Dilip Soni, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-495-6325 Fax: 908-788-6106 |
News Archive
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research.
A study of 64,659 women, recently published in the journal Academic Radiology, found that while 1,246 of these women were at high enough breast cancer risk to recommend additional screening with MRI, only 173 of these women returned to the clinic within a year for the additional screening.
Researchers have developed ‘nano-sized' probes built from DNA that can seek and destroy cancer cells, leaving healthy cells untouched. These ‘nanorobots' release their drug payload only when they reach and identify their target and are believed to improve many treatments for disease.
High-throughput analysis of blood plasma could aid in identification of diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis (ALS), according to research from North Carolina State University.
Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy.
› Verified 4 days ago